Genomic surveillance during the coronavirus disease 2019 (COVID-19) pandemic has been
key to the timely identification of virus variants with important public health consequences …

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, numerous
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have emerged …

The onset of the COVID-19 pandemic accelerated the implementation of genomic
surveillance of its causal agent, SARS-CoV-2, on a global scale. As of April 6, 2023, there …

The rapid emergence of SARS-CoV-2 variants raised public health questions concerning
the capability of diagnostic tests to detect new strains, the efficacy of vaccines, and how to …

The COVID-19 pandemic has brought significant challenges for genomic surveillance
strategies in public health systems worldwide. During the past thirty-four months, many …

Since the beginning of the SARS-CoV-2 pandemic, there has been international concern
about the emergence of virus variants with mutations that increase transmissibility, enhance …

Abstract Background The Centers for Disease Control and Prevention contracted with
laboratories to sequence the SARS-CoV-2 genome from positive samples across the United …

ABSTRACT SARS-CoV-2 molecular testing coupled with whole-genome sequencing is
instrumental for real-time genomic surveillance. Genomic surveillance is critical for …

Global SARS-CoV-2 genomic surveillance efforts have provided critical data on the ongoing
evolution of the virus to inform best practices in clinical care and public health throughout the …

Background Genomic surveillance efforts for SARS-CoV-2 are needed to understand the
epidemiology of the COVID-19 pandemic. Viral variants may impact routine diagnostic …